Importance of DCTs Moving Forward

How today’s SSO reduces site burden and spearheads clinical system interoperability.

With close collaboration between sponsors, CROs, and regulators, this emerging technology has the potential to greatly improve the lives of patients.

An increase in protocol complexity is paving the way for machine learning models to optimize trial design.

Examining the implications of the recent US executive orders concerning diversity, equity, and inclusion pursuits—and the key questions each clinical trial stakeholder must now navigate.

The future of clinical trial design involves incorporating the patient experience into strategic asset planning.

Anticipating divestment, reallocation of investments, and retrenchment.